Results 211 to 220 of about 161,793 (289)
Latviešu Ārstu un Zobārstu Apvienības goda biedra profesora Dr. med. Jēkaba Alkšņa dzīves gaita
AML Medicīnas vēstures institūts
doaj +1 more source
Current Knowledge of the Integrated Stress Response in the Development and Management of Acute Myeloid Leukemia: A Novel Target with Encouraging Progress. [PDF]
Jiang W +6 more
europepmc +1 more source
Summary The efficacy of a triple combination of rabbit anti‐human thymocyte immunoglobulin (rATG), ciclosporin and eltrombopag (EPAG) was prospectively evaluated in patients with severe or transfusion‐dependent non‐severe aplastic anaemia (SAA) across 29 institutions in Japan. Sixty patients were enrolled, of whom 48 had SAA. The primary end‐point, the
Fumi Nakamura +17 more
wiley +1 more source
Prediction of prognosis and immunotherapy response of tryptophan metabolism genes in acute myeloid leukemia. [PDF]
Zhong T +8 more
europepmc +1 more source
Summary Small nucleolar ribonucleic acids (snoRNAs) are a class of small non‐coding RNAs involved in the post‐transcriptional modification of ribosomal RNAs (rRNA) and small nuclear RNAs (snRNA). Mounting evidence indicates that specific snoRNAs are drivers of oncogenesis, but their role in B‐cell precursor acute lymphoblastic leukaemia (BCP‐ALL) is ...
Martijn W. C. Verbeek +13 more
wiley +1 more source
IL-1 signaling and inflammasomes in acute myeloid leukemia: mechanisms and therapeutic opportunities. [PDF]
Mortellaro A, Mastaglio S, Muzio M.
europepmc +1 more source
We show how the loss of activity of the translation initiation factor EIF5A2—either through gene hypermethylation or pharmacologic inhibition of its highly specific hypusine post‐translational modification—induces venetoclax sensitivity in acute myeloid leukaemia (AML) cells.
Eva Crespo‐García +5 more
wiley +1 more source

